Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/refractory multiple myeloma
- Hee Jeong Cho1, Jae-Cheol Jo2, Yoo Jin Lee2, Myung Won Lee3, Do Young Kim4, Ho Jin Shin4, Sung Nam Im5, Ji Hyun Lee6, Sung Hwa Bae7, Young Rok Do8, Won Sik Lee9, Min Kyung Kim10, Jina Jung1, Jung Min Lee1, Ju-Hyung Kim1, Dong Won Baek1, Sang-Kyun Sohn1, Joon Ho Moon1
Korean J Intern Med 2023;38:238-247
In the article cited above, there was an error in the chart legend in Supplementary Fig. 4. The corrected legend is as following:
We apologize for any inconvenience that this may have caused.